2,4-Diaryl-pyrimido[1,2-a]benzimidazole derivatives as novel anticancer agents endowed with potent anti-leukemia activity: Synthesis, biological evaluation and kinase profiling
        2,4-Diaryl-pyrimido[1,2-a]benzimidazole derivatives as novel anticancer agents endowed with potent anti-leukemia activity: Synthesis, biological evaluation and kinase profiling.        
                  European Journal of Medicinal Chemistry.                
                  2023,
                
                              258,
                  
                              115610,
                          
                  ISSN: 0223-5234,
                
                
                              PMID: 37437350,                          
                
                          
        
      
    